GOLPH3 and prostate carcinoma: Number (percentage) of patients in groups differing in the intensity of staining in GOLPH3 positive prostate cancer cells (“B” score in IRS scale) in the material from the prostate or metastatic lymph node, risk factors, and results of chi-square tests of independence.